Sales Support:

U.S.A:
+1-415-871-0703
UK:
+44-203-289-4040
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Opioid-Induced Constipation Revenue 1.5 Market Analysis by Type 1.5.1 Global Opioid-Induced Constipation Market Size Growth Rate by Type: 2020 VS 2026 1.5.2 Methylnaltrexone Bromide 1.5.3 Lubiprostone 1.5.4 Naloxegol 1.5.5 Others 1.6 Market by Application 1.6.1 Global Opioid-Induced Constipation Market Share by Application: 2021-2026 1.6.2 Hospital 1.6.3 Pharmacy 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Opioid-Induced Constipation Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter's Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Opioid-Induced Constipation Market Players Profiles 3.1 Takeda Pharmaceuticals 3.1.1 Takeda Pharmaceuticals Company Profile 3.1.2 Takeda Pharmaceuticals Opioid-Induced Constipation Product Specification 3.1.3 Takeda Pharmaceuticals Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.2 Purdue Pharm 3.2.1 Purdue Pharm Company Profile 3.2.2 Purdue Pharm Opioid-Induced Constipation Product Specification 3.2.3 Purdue Pharm Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.3 Mallinckrodt 3.3.1 Mallinckrodt Company Profile 3.3.2 Mallinckrodt Opioid-Induced Constipation Product Specification 3.3.3 Mallinckrodt Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 Bayer 3.4.1 Bayer Company Profile 3.4.2 Bayer Opioid-Induced Constipation Product Specification 3.4.3 Bayer Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 Progenics Pharmaceuticals 3.5.1 Progenics Pharmaceuticals Company Profile 3.5.2 Progenics Pharmaceuticals Opioid-Induced Constipation Product Specification 3.5.3 Progenics Pharmaceuticals Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 Sanofi 3.6.1 Sanofi Company Profile 3.6.2 Sanofi Opioid-Induced Constipation Product Specification 3.6.3 Sanofi Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.7 Daiichi Sankyo 3.7.1 Daiichi Sankyo Company Profile 3.7.2 Daiichi Sankyo Opioid-Induced Constipation Product Specification 3.7.3 Daiichi Sankyo Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.8 AstraZeneca 3.8.1 AstraZeneca Company Profile 3.8.2 AstraZeneca Opioid-Induced Constipation Product Specification 3.8.3 AstraZeneca Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.9 Salix (Bausch Health) 3.9.1 Salix (Bausch Health) Company Profile 3.9.2 Salix (Bausch Health) Opioid-Induced Constipation Product Specification 3.9.3 Salix (Bausch Health) Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.10 Nektar Therapeutics 3.10.1 Nektar Therapeutics Company Profile 3.10.2 Nektar Therapeutics Opioid-Induced Constipation Product Specification 3.10.3 Nektar Therapeutics Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.11 Prestige 3.11.1 Prestige Company Profile 3.11.2 Prestige Opioid-Induced Constipation Product Specification 3.11.3 Prestige Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.12 GSK 3.12.1 GSK Company Profile 3.12.2 GSK Opioid-Induced Constipation Product Specification 3.12.3 GSK Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.13 Shionogi 3.13.1 Shionogi Company Profile 3.13.2 Shionogi Opioid-Induced Constipation Product Specification 3.13.3 Shionogi Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global Opioid-Induced Constipation Market Competition by Market Players 4.1 Global Opioid-Induced Constipation Production Capacity Market Share by Market Players (2015-2020) 4.2 Global Opioid-Induced Constipation Revenue Market Share by Market Players (2015-2020) 4.3 Global Opioid-Induced Constipation Average Price by Market Players (2015-2020) 5 Global Opioid-Induced Constipation Production by Regions (2015-2020) 5.1 North America 5.1.1 North America Opioid-Induced Constipation Market Size (2015-2020) 5.1.2 Opioid-Induced Constipation Key Players in North America (2015-2020) 5.1.3 North America Opioid-Induced Constipation Market Size by Type (2015-2020) 5.1.4 North America Opioid-Induced Constipation Market Size by Application (2015-2020) 5.2 East Asia 5.2.1 East Asia Opioid-Induced Constipation Market Size (2015-2020) 5.2.2 Opioid-Induced Constipation Key Players in East Asia (2015-2020) 5.2.3 East Asia Opioid-Induced Constipation Market Size by Type (2015-2020) 5.2.4 East Asia Opioid-Induced Constipation Market Size by Application (2015-2020) 5.3 Europe 5.3.1 Europe Opioid-Induced Constipation Market Size (2015-2020) 5.3.2 Opioid-Induced Constipation Key Players in Europe (2015-2020) 5.3.3 Europe Opioid-Induced Constipation Market Size by Type (2015-2020) 5.3.4 Europe Opioid-Induced Constipation Market Size by Application (2015-2020) 5.4 South Asia 5.4.1 South Asia Opioid-Induced Constipation Market Size (2015-2020) 5.4.2 Opioid-Induced Constipation Key Players in South Asia (2015-2020) 5.4.3 South Asia Opioid-Induced Constipation Market Size by Type (2015-2020) 5.4.4 South Asia Opioid-Induced Constipation Market Size by Application (2015-2020) 5.5 Southeast Asia 5.5.1 Southeast Asia Opioid-Induced Constipation Market Size (2015-2020) 5.5.2 Opioid-Induced Constipation Key Players in Southeast Asia (2015-2020) 5.5.3 Southeast Asia Opioid-Induced Constipation Market Size by Type (2015-2020) 5.5.4 Southeast Asia Opioid-Induced Constipation Market Size by Application (2015-2020) 5.6 Middle East 5.6.1 Middle East Opioid-Induced Constipation Market Size (2015-2020) 5.6.2 Opioid-Induced Constipation Key Players in Middle East (2015-2020) 5.6.3 Middle East Opioid-Induced Constipation Market Size by Type (2015-2020) 5.6.4 Middle East Opioid-Induced Constipation Market Size by Application (2015-2020) 5.7 Africa 5.7.1 Africa Opioid-Induced Constipation Market Size (2015-2020) 5.7.2 Opioid-Induced Constipation Key Players in Africa (2015-2020) 5.7.3 Africa Opioid-Induced Constipation Market Size by Type (2015-2020) 5.7.4 Africa Opioid-Induced Constipation Market Size by Application (2015-2020) 5.8 Oceania 5.8.1 Oceania Opioid-Induced Constipation Market Size (2015-2020) 5.8.2 Opioid-Induced Constipation Key Players in Oceania (2015-2020) 5.8.3 Oceania Opioid-Induced Constipation Market Size by Type (2015-2020) 5.8.4 Oceania Opioid-Induced Constipation Market Size by Application (2015-2020) 5.9 South America 5.9.1 South America Opioid-Induced Constipation Market Size (2015-2020) 5.9.2 Opioid-Induced Constipation Key Players in South America (2015-2020) 5.9.3 South America Opioid-Induced Constipation Market Size by Type (2015-2020) 5.9.4 South America Opioid-Induced Constipation Market Size by Application (2015-2020) 5.10 Rest of the World 5.10.1 Rest of the World Opioid-Induced Constipation Market Size (2015-2020) 5.10.2 Opioid-Induced Constipation Key Players in Rest of the World (2015-2020) 5.10.3 Rest of the World Opioid-Induced Constipation Market Size by Type (2015-2020) 5.10.4 Rest of the World Opioid-Induced Constipation Market Size by Application (2015-2020) 6 Global Opioid-Induced Constipation Consumption by Region (2015-2020) 6.1 North America 6.1.1 North America Opioid-Induced Constipation Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Opioid-Induced Constipation Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Opioid-Induced Constipation Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Opioid-Induced Constipation Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Opioid-Induced Constipation Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Opioid-Induced Constipation Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Opioid-Induced Constipation Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Opioid-Induced Constipation Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Opioid-Induced Constipation Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Opioid-Induced Constipation Consumption by Countries 7 Global Opioid-Induced Constipation Production Forecast by Regions (2021-2026) 7.1 Global Forecasted Production of Opioid-Induced Constipation (2021-2026) 7.2 Global Forecasted Revenue of Opioid-Induced Constipation (2021-2026) 7.3 Global Forecasted Price of Opioid-Induced Constipation (2021-2026) 7.4 Global Forecasted Production of Opioid-Induced Constipation by Region (2021-2026) 7.4.1 North America Opioid-Induced Constipation Production, Revenue Forecast (2021-2026) 7.4.2 East Asia Opioid-Induced Constipation Production, Revenue Forecast (2021-2026) 7.4.3 Europe Opioid-Induced Constipation Production, Revenue Forecast (2021-2026) 7.4.4 South Asia Opioid-Induced Constipation Production, Revenue Forecast (2021-2026) 7.4.5 Southeast Asia Opioid-Induced Constipation Production, Revenue Forecast (2021-2026) 7.4.6 Middle East Opioid-Induced Constipation Production, Revenue Forecast (2021-2026) 7.4.7 Africa Opioid-Induced Constipation Production, Revenue Forecast (2021-2026) 7.4.8 Oceania Opioid-Induced Constipation Production, Revenue Forecast (2021-2026) 7.4.9 South America Opioid-Induced Constipation Production, Revenue Forecast (2021-2026) 7.4.10 Rest of the World Opioid-Induced Constipation Production, Revenue Forecast (2021-2026) 7.5 Forecast by Type and by Application (2021-2026) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026) 7.5.2 Global Forecasted Consumption of Opioid-Induced Constipation by Application (2021-2026) 8 Global Opioid-Induced Constipation Consumption Forecast by Regions (2021-2026) 8.1 North America Forecasted Consumption of Opioid-Induced Constipation by Country 8.2 East Asia Market Forecasted Consumption of Opioid-Induced Constipation by Country 8.3 Europe Market Forecasted Consumption of Opioid-Induced Constipation by Countriy 8.4 South Asia Forecasted Consumption of Opioid-Induced Constipation by Country 8.5 Southeast Asia Forecasted Consumption of Opioid-Induced Constipation by Country 8.6 Middle East Forecasted Consumption of Opioid-Induced Constipation by Country 8.7 Africa Forecasted Consumption of Opioid-Induced Constipation by Country 8.8 Oceania Forecasted Consumption of Opioid-Induced Constipation by Country 8.9 South America Forecasted Consumption of Opioid-Induced Constipation by Country 8.10 Rest of the world Forecasted Consumption of Opioid-Induced Constipation by Country 9 Global Opioid-Induced Constipation Sales by Type (2015-2026) 9.1 Global Opioid-Induced Constipation Historic Market Size by Type (2015-2020) 9.2 Global Opioid-Induced Constipation Forecasted Market Size by Type (2021-2026) 10 Global Opioid-Induced Constipation Consumption by Application (2015-2026) 10.1 Global Opioid-Induced Constipation Historic Market Size by Application (2015-2020) 10.2 Global Opioid-Induced Constipation Forecasted Market Size by Application (2021-2026) 11 Global Opioid-Induced Constipation Manufacturing Cost Analysis 11.1 Opioid-Induced Constipation Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Opioid-Induced Constipation 12 Global Opioid-Induced Constipation Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Opioid-Induced Constipation Distributors List 12.3 Opioid-Induced Constipation Customers 12.4 Opioid-Induced Constipation Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Price : US$ 2,000 | Date : Dec 2020 |
Category : Medical Devices | Pages : 132 |
Price : US$ 3,000 | Date : Dec 2020 |
Category : Medical Devices | Pages : 114 |
Price : US$ 3,000 | Date : Dec 2020 |
Category : Medical Devices | Pages : 96 |
Price : US$ 3,000 | Date : Dec 2020 |
Category : Medical Devices | Pages : 114 |
Price : US$ 3,000 | Date : Dec 2020 |
Category : Medical Devices | Pages : 124 |
We will be happy to help you find what you need. Please call us or write to us: